Purpose-built for physicians GLP-1 agents can help lower systemic inflammation, show promise in rheumatology The apparent success and now almost ever-present ubiquity of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, including those under rheumatology umbrella
This is where innovative solutions step in to bridge the gap between effort and sustainability
Mori, R., Ukai, J., Tokumaru, Y., Niwa, Y
What Areas Can We Treat with B12 Injections
GLP-1RA inhibit endothelial cell dysfunction while attenuating abnormal migration, proliferation, and apoptosis in VSMCs